Back to Search
Start Over
PACE: A Randomized Phase II Study of Fulvestrant, Palbociclib, and Avelumab After Progression on Cyclin-Dependent Kinase 4/6 Inhibitor and Aromatase Inhibitor for Hormone Receptor–Positive/Human Epidermal Growth Factor Receptor–Negative...
- Source :
- Journal of Clinical Oncology; 6/10/2024, Vol. 42 Issue 17, p2050-2060, 13p
- Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 0732183X
- Volume :
- 42
- Issue :
- 17
- Database :
- Supplemental Index
- Journal :
- Journal of Clinical Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 177717045
- Full Text :
- https://doi.org/10.1200/JCO.23.01940